Theresa Perrin
Self-Directed Investor & Trader, Former Hospice Nurse
China SXT Pharmaceuticals is a short-squeeze candidate: short interest exceeds 20%, institutional ownership exceeds 100%, no shares are left to borrow and the cost to borrow is over 500%. It has the same setup as other low-float, high-short-interest plays; after coiling all day, a pop on incoming volume is only a matter of time because shorts are trapped. x.com x.comÂ
Twist Bioscience is squeeze material, with a small float and 19% short interest. It is a former IBD sector leader and a rare biotech with revenue. x.comÂ
Treasure Global's pre-market surge lacks a clear fresh catalyst; its smart-water-metering acquisition MOU and AI distribution agreements are older potential narrative hooks. Delisting risk remains, though hard-to-borrow shares and a 7/10 squeeze rating complicate a fade. x.comÂ
Xiao-I is one to avoid despite a 19% jump. Its update on the patent lawsuit against Apple offers a possible narrative, but the stock is hard to borrow, carries delisting risk and has a squeeze risk of 8/10. x.comÂ
Applied Digital looks set for a strong bounce as heavy buying pressure meets a crowded short base. Buyer-pressure readings are almost three times the spike seen near the March bottom, just before the stock exploded higher, and the bottom signals from then are back, bigger and more prolonged. Short interest is above 23% of the float with off-exchange activity above 70%, making a squeeze more likely, and a tightly compressed bullish pennant could resolve higher in the next few weeks if it holds. … Show more
SGRX is one to avoid, with delisting risk and no clear catalyst behind its 14% jump. Squeeze risk rates 6 out of 10. x.comÂ
KULR Technology is set up for a short squeeze, with short interest above the 20% threshold on a float of 44M shares. It makes batteries for defense, transportation and space, reports earnings tomorrow after the bell and has technical momentum, with $6.00 the next major level. x.comÂ
Lumentum is set up for a short squeeze at new all-time highs, given its small float and 16% short interest. x.comÂ
Quanome Technologies' 124% gap up on its AI and quantum story looks set to fade, with a $1.00 target. With a $49M market cap, a 25.8M-share float and only 4.7% short interest, the large float and low short interest make for a weak squeeze setup. Insider selling is likely on a big gap, and S-3 filings could bring dilution. x.comÂ
Allbirds looks set to grind higher as it runs out of shares to borrow, with the borrow rate up to 330%. Shorts are being sucked in while algos try to take control of the float, and little new borrow is expected to come online, so the move should continue for the next few days. x.com x.comÂ
BitFuFu's 25% jump looks shortable, with no clear catalyst beyond a sympathy move with bitcoin miners. Short interest is just 0.8% of a 19.7 million-share float, putting squeeze risk at about 20%. x.comÂ
